Perfil
Andrew H.
Chang worked as a Director of Investor Relations at Astellas Gene Therapies, Inc. and later as the Head of Investor Relations and Corporate Communication at Applied Molecular Transport, Inc. from 2020 to 2023.
Antiguos cargos conocidos de Andrew H. Chang.
Empresas | Cargo | Fin |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Contacto de Relaciones con Inversores | 27/12/2023 |
AUDENTES THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/01/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew H. Chang